Politics – By Gene Emery BOSTON (Reuters) - Bayer AG is removing remaining supplies of its heart-surgery drug Trasylol from the US market after a long-awaited study found it raised the risk of death compared to two alternatives, US regulators said on Wednesday.
Not a member? Sign-up today!
About Propeller | Frequently Asked Questions | Help
© 2003-2008 Propeller. All Rights Reserved. Terms of Use | Privacy Policy
0)
Vote